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Introduction
Guillain-Barre syndrome is considered as an immune mediated acute inflammatory 
demyelinating polyradiculoneuropathy with rapid development of motor weakness. 
GBS has a wide range of variants with distinct features. The most common 
prototype is acute inflammatory demyelinating polyneuropathy (AIDP). The 
less common forms are axonal neuropathies which include, acute motor axonal 
neuropathy (AMAN), acute motor and sensory axonal neuropathy (AMSAN) and 
Miller Fisher syndrome (1). Approximately 50% of patients with GBS develop 
cranial neuropathy. However, facial or ocular muscles are affected first. The most 
common cranial nerve involvement is facial, whilst ocular muscle weakness is seen 
in 10% of patients. Moreover, eyelid levators are less affected common than other 
oculomotor muscles (2). Thus, at the onset of GBS, the presence of ptosis without 
ophthalmoplegia is rare. In this study, we report a case of GBS where the patient 
initially presented with bilateral ptosis without ophthalmoplegia or ataxia and, 
afterwards, developed ascending paralysis.
Case Report
A previously healthy 10-year-old girl was presented with painless bilateral ptosis, 
which she had been suffering with for two days. At first, the ptosis only affected 
the left eye. However, following several hours, the right eye was also affected. 
The ptosis did not have any diurnal fluctuation and the patient was hospitalized. 
Two days later, she noticed a progressive weakness in her limbs, especially in 
the lower extremities. This meant that she was unable to walk. Her vaccinations 
were documented as up to date. She had no history of any flu-like diseases or 
recent gastrointestinal infections. Furthermore, a neurologic examination revealed 
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Guillain-Barre syndrome (GBS) is the most common cause of acute weakness 
in children. It has multiple variant forms with different presentations. A rare 
initial sign is ptosis. In this study, we present a 10-year-old girl with bilateral 
ptosis without opthalmoplegia followed by a weakness in extremities with a 
favourable response to intravenous immunoglobulin. Due to the patient’s 
initial eyelid levators, myasthenia gravis was ruled out by a Tensilon test and 
electrophysiological studies. Our report highlights the possibility of GBS as a 
cause of isolated ptosis, especially in cases without ophthalmoplegia. 
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that her mental status was normal. There was bilateral 
ptosis (Figure 1). Her eye movements were normal 
and her pupils were of normal size, symmetric and 
reactive to light. Other cranial nerves were also normal. 
The muscle forces of her upper and lower limbs 
were 4/5 and 3/5, respectively. Her tendon reflexes 
had significantly decreased in all extremities and no 
Babinsky signs were detected. She did not reveal any 
abnormalities in sensory, sphincteric and coordinating 
examinations. Additionally, her haematological and 
biochemical tests, such as liver, renal, thyroid functions, 
glucose and electrolytes, were normal. The Tensilon 
test was non-reactive. Furthermore, her brain and 
spinal MRIs were normal. There were no abnormalities 
in her cerebrospinal fluid (CSF), except for protein 
102 mg/dl. Electrophysiological studies revealed 
acute polyneuropathy. Intravenous immunoglobulin 
(IVIG) was started for the patient (2g/kg), with a rapid 
resolution of muscle weakness. After a week, she 
walked without assistance. Three weeks later, the ptosis 
had significantly improved and in her follow up visits, it 
had disappeared completely (Figure 2).
Discussion
Besides the typical acute inflammatory demyelinating 
polyneuropathy (AIDP) manifesting as areflexia and 
ascending paralysis peaking during a month, several 
known variants including axonal deficit, pure motor, 
sensory or autonomic involvement, Miller Fisher 
syndrome (MFS) and other local form are reported 
(3,4). For a patient with acute isolated ptosis, a complete 
neurologic examination is mandatory to distinguish 
whether the ptosis is isolated or not. Central nervous 
system (CNS) imaging, such as MRI, is suggested in 
cases where there are eye motion limitations, pupillary 
or visual disturbances, local weakness, other cranial 
nerve disorders and some atypical features, in addition to 
the ptosis. Neurologic consultation is usually necessary. 
After the exclusion of a mass lesion in brainstem and 
phenytoin poisoning, neuromuscular disorders must be 
considered (5). Having the first manifestation of cases 
with acute inflammatory neuropathy as ptosis without 
ophthalmoplegia is very rare. However, in MFS, ptosis 
with ophthalmoplegia is common (5). In our case, there 
were some findings which supported a diagnosis of GBS 
over MFS. The first was the absence of ophthalmoplegia 
and ataxia during the course of disease. The second 
finding that supported our diagnosis was that protein 
cell dissociation in CSF is uncommon in MFS. Acute 
isolated bilateral ptosis is more often observed in 
myasthenia gravis (MG) patients. Furthermore, cases of 
MG and GBS can later develop generalized paralysis. 
The diagnosis of MG was unlikely in our patient. This 
was due to the lack of response to the Tensilon test, 
lack of diurnal variety of symptoms and the results 
of the electrophysiological evaluations. One of the 
neuromuscular junction disorders, such as botulism, can 
also cause generalized paralysis and ptosis (6). In our 
patient, normal pupillary function led to the exclusion 
of botulism. More than 85% of cases with GBS with 
ophthalmoplegia and MFS have a positive anti-GQ1b 
IgG antibody. However, it is rarely positive among 
GBS patients without ophthalmoplegia (7). Stalpers et 
al. presented a GBS patient with isolated bilateral ptosis 
and ataxia (8). They had not achieved acute phase anti-
GQb1 IgG. Teng and Sung (9) reported a GBS patient 
with ptosis at the onset of disease. No anti-GQ1b IgG or 
CSF analysis was performed. In our study, serum anti-
GQ1b IgG was not measured. During an investigation 
of 33 GBS patients by Karimzadeh et al.  (10), 24.3% 
had atypical presentations. These included: ptosis 
(3%), upper extremities weakness (3%), proximal 
weakness (9.1%), dysphagia (3%), headache (3%) 
and neck stiffness (3%). Furthermore, a descending 
weakness was seen in 15.2%, cranial neuropathy in 
24.3% and facial nerve palsy in 9.1%. According to a 
normal brain MRI, a characteristic electrophysiological 
pattern compatible with acute polyneuropathy, normal 
pupillary function, no response to Tensilon test, 
albuminocytologic dissociation in CSF, pure ptosis 
without ophthalmoplegia and ataxia, no diurnal change 
in ptosis, ascending symmetric weakness of extremities 
in our patient, her diagnosis was consistent with GBS. 
The diagnosis of GBS should be kept in mind in 
patients with isolated ptosis and ptosis with ascending 
or descending paralysis of cranial or extremities. 
Furthermore, electrophysiological studies should be 
taken into consideration in cases with myasthenia gravis 
disorders. Furthermore, anti-GQ1b could differentiate 
some variants of GBS.
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Fig 2. Resolution of ptosis a month after IVIG treatment.
Fig 1. Bilateral ptosis at onset of disease.
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